HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 262 filers reported holding HAEMONETICS CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $1,366,000 | -37.8% | 18,675 | -50.6% | 0.01% | -38.5% |
Q4 2017 | $2,195,000 | +31.5% | 37,800 | +1.6% | 0.01% | +30.0% |
Q3 2017 | $1,669,000 | +8.4% | 37,200 | -4.6% | 0.01% | +11.1% |
Q2 2017 | $1,539,000 | -25.9% | 38,975 | -23.9% | 0.01% | -25.0% |
Q1 2017 | $2,077,000 | +11.4% | 51,200 | +10.3% | 0.01% | 0.0% |
Q4 2016 | $1,865,000 | +14.6% | 46,405 | +3.3% | 0.01% | +20.0% |
Q3 2016 | $1,627,000 | +23.9% | 44,925 | -0.8% | 0.01% | +11.1% |
Q2 2016 | $1,313,000 | -19.4% | 45,300 | -2.8% | 0.01% | -18.2% |
Q1 2016 | $1,630,000 | +6.5% | 46,600 | -1.9% | 0.01% | +10.0% |
Q4 2015 | $1,531,000 | +8.1% | 47,500 | +8.4% | 0.01% | 0.0% |
Q3 2015 | $1,416,000 | -4.9% | 43,800 | +21.7% | 0.01% | 0.0% |
Q2 2015 | $1,489,000 | -9.5% | 36,000 | -1.7% | 0.01% | -9.1% |
Q1 2015 | $1,645,000 | +71.5% | 36,630 | +42.9% | 0.01% | +83.3% |
Q4 2014 | $959,000 | -84.4% | 25,630 | -82.7% | 0.01% | -73.9% |
Q1 2013 | $6,156,000 | -44.8% | 147,782 | -45.9% | 0.02% | -47.7% |
Q4 2012 | $11,158,000 | – | 273,220 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |